Quarterly report pursuant to Section 13 or 15(d)

Earnings Per Share (Tables)

v3.19.2
Earnings Per Share (Tables)
6 Months Ended
Jun. 30, 2019
Earnings Per Share [Abstract]  
Summary of anti-dilutive equivalent units outstanding excluded from earnings per share calculation
The following table summarizes equivalent units outstanding that were excluded from the earnings per share calculation because their effects were anti-dilutive (in thousands):
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2019
 
2018
 
2019
 
2018
Common stock purchase warrants
8,378

 
10,055

 
8,378

 
10,055

Stock options
1,743

 
3,085

 
1,743

 
3,085

Convertible note
4,710

 

 
4,710

 

Advance from NovellusDx, Ltd.
2,819

 

 
2,819

 

Restricted shares of common stock
19

 
57

 
19

 
57

 
17,669

 
13,197

 
17,669

 
13,197